Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

References

• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249–57.
   PubMed Web of Science ®Google Scholar
• Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518:187–96.
   PubMed Web of Science ®Google Scholar
• Prasad RB, Groop L. Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel). 2015;6:87–123.
   PubMed Web of Science ®Google Scholar
• Hinton RB. Genetic and environmental factors contributing to cardiovascular malformation: a unified approach to risk. J Am Heart Assoc. 2013;2:e000292.
   PubMed Web of Science ®Google Scholar
• Speakman JR. Obesity: the integrated roles of environment and genetics. J Nutr. 2004;134:2090S–105S.
   PubMed Web of Science ®Google Scholar
• Stefan N, Fritsche A, Haring H, Stumvoll M. Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator–activated receptor-gamma2 gene. Diabetes. 2001;50:1143–8.
   PubMed Web of Science ®Google Scholar
• Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, et al. The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia. 2006;49:158–68.
   PubMed Web of Science ®Google Scholar
• Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, et al. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest. 2013;123:3378–82.
   PubMed Web of Science ®Google Scholar
• Lee BP, Lloyd-Laney HO, Locke JM, McCulloch LJ, Knight B, Yaghootkar H, et al. Functional characterisation of ADIPOQ variants using individuals recruited by genotype. Mol Cell Endocrinol. 2016;428:49–57.
   PubMed Web of Science ®Google Scholar
• Tang Y, Axelsson AS, Spegel P, Andersson LE, Mulder H, Groop LC, et al. Genotype-based treatment of type 2 diabetes with an alpha2A-adrenergic receptor antagonist. Sci Transl Med. 2014;6:257ra139.
   PubMed Web of Science ®Google Scholar
• Herrmann J, Rubin D, Hasler R, Helwig U, Pfeuffer M, Auinger A, et al. Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study. Lipids Health Dis. 2009;8:35.
   PubMed Web of Science ®Google Scholar
• Rubin D, Herrmann J, Much D, Pfeuffer M, Laue C, Winkler P, et al. Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARgamma2 Pro12Ala polymorphism. Genes Nutr. 2012;7:499–509.
   PubMed Web of Science ®Google Scholar
• Pihlajamaki J, Schwab U, Kaminska D, Ågren J, Kuusisto J, Kolehmainen M, et al. Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial. Genes Nutr. 2015;10:43.
   PubMed Web of Science ®Google Scholar
• Lind L, Elmstahl S, Bergman E, Englund M, Lindberg E, Michaelsson K, et al. EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases. Eur J Epidemiol. 2013;28:189–97.
   PubMed Web of Science ®Google Scholar
• EpiHealth. Epihealth 2011. Available from: https://www.epihealth.se
   Google Scholar
• Berglund L, Berne C, Svardsudd K, Garmo H, Melhus H, Zethelius B. Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men. Ups J Med Sci. 2012;117:35–40.
   PubMed Web of Science ®Google Scholar
• ULSAM. Uppsala Longitudinal Study of Adult Men 2017. Available from: http://www.pubcare.uu.se/ulsam
   Google Scholar
• Goldstein JI, Crenshaw A, Carey J, Grant GB, Maguire J, Fromer M, et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics. 2012;28:2543–5.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
   PubMed Web of Science ®Google Scholar
• Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab. 2001;86:4776–81.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–10.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–70.
   PubMed Web of Science ®Google Scholar
• Chen X, Levine L, Kwok PY. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res. 1999;9:492–8.
   PubMed Web of Science ®Google Scholar
• Team RC. R: A language and environment for statistical computing. 2017. Available from: https://www.r-project.org/
   Google Scholar
• Stranger BE, Stahl EA, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics. 2011;187:367–83.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S, et al. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes. 2001;50:876–81.
   PubMed Web of Science ®Google Scholar
• Jacob S, Stumvoll M, Becker R, Koch M, Nielsen M, Löblein K, et al. The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm Metab Res. 2000;32:413–16.
   PubMed Web of Science ®Google Scholar
• Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80.
   PubMed Web of Science ®Google Scholar
• Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, et al. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord. 2000;24:195–9.
   PubMed Web of Science ®Google Scholar
• Beskow LM, Linney KN, Radtke RA, Heinzen EL, Goldstein DB. Ethical challenges in genotype-driven research recruitment. Genome Res. 2010;20:705–9.
   PubMed Web of Science ®Google Scholar
• Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS. Recommendations for ethical approaches to genotype-driven research recruitment. Hum Genet. 2012;131:1423–31.
   PubMed Web of Science ®Google Scholar
• Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557–66.
   PubMed Web of Science ®Google Scholar
• Yanase T, Yashiro T, Takitani K, Kato S, Taniguchi S, Takayanagi R, et al. Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue. Biochem Biophys Res Commun. 1997;233:320–4.
   PubMed Web of Science ®Google Scholar
• Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem. 1997;272:18779–89.
   PubMed Web of Science ®Google Scholar
• Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 1997;241:270–4.
   PubMed Web of Science ®Google Scholar
• Tonjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006;29:2489–97.
   PubMed Web of Science ®Google Scholar
• Mansoori A, Amini M, Kolahdooz F, Seyedrezazadeh E. Obesity and Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene in healthy adults: a systematic review and meta-analysis. Ann Nutr Metab. 2015;67:104–18.
   PubMed Web of Science ®Google Scholar
• Galbete C, Toledo E, Martinez-Gonzalez MA, Martínez JA, Guillén-Grima F, Marti A. Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-analysis encompassing 49,092 subjects. Obesity (Silver Spring). 2013;21:1486–95.
   PubMed Web of Science ®Google Scholar
• Barbieri M, Rizzo MR, Papa M, Acampora R, De Angelis L, Olivieri F, et al. Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol. 2005;40:599–604.
   PubMed Web of Science ®Google Scholar
• Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol. 2001;144:277–82.
   PubMed Web of Science ®Google Scholar
• Iwata E, Matsuda H, Fukuda T, Fukuen S, Motomura T, Igarashi T, et al. Mutations of the peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in a Japanese population: the Pro12Ala mutation in PPAR gamma 2 is associated with lower concentrations of serum total and non-HDL cholesterol. Diabetologia. 2001;44:1354–5.
   PubMed Web of Science ®Google Scholar
• Hamada T, Kotani K, Tsuzaki K, Sano Y, Murata T, Tabata M, et al. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population. Metabolism. 2007;56:1345–9.
   PubMed Web of Science ®Google Scholar
• Tai ES, Corella D, Deurenberg-Yap M, Adiconis X, Chew SK, Tan CE, et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004;45:674–85.
   PubMed Web of Science ®Google Scholar
• Robitaille J, Despres JP, Perusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet. 2003;63:109–16.
   PubMed Web of Science ®Google Scholar
• Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, et al.; Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–83.
   PubMed Web of Science ®Google Scholar